## Abstract Serum from hepatoma‐bearing rats has been shown to abrogate the cytotoxicity of immune lymph‐node cells when added to the target cells (blocking) or the effector cells (inhibition). Neutralization of these in vitro blocking and inhibitory reactions by sera containing antibody to tumour
Subpopulations of multiparous rat lymph-node cells cytotoxic for rat tumour cells and capable of suppressing cytotoxicity in vitro
✍ Scribed by R. C. Rees; Judith Bray; R. A. Robins; R. W. Baldwin
- Publisher
- John Wiley and Sons
- Year
- 1975
- Tongue
- French
- Weight
- 759 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Lymph‐node cells (LNC) from multiparous pregnant rats were separated on columns prepared from nylon wool, and tested for cytotoxicity against target tumour cells. Reactivity of LNC towards hepatoma D23 and mammary carcinoma AAF57 was demonstrated in cell populations retained on the nylon wool, and not with cells eluted from the column. Although only 25% of the samples of unfractionated LNC were cytotoxic for tumour cells, retained cell fractions were cytotoxic in 11 out of 12 tests (p = <0.05). Similarly retained LNC were also cytotoxic for 15‐day‐old embryo cells but not for normal adult rat fibroblasts. Using multiparous rat serum it was shown that the reactivity of the retained LNC population could be abrogated in eight out of 11 tests (p = <0.05). The LNC population recovered from the nylon wool constituted 28 to 35% of the original LNC preparation, and consisted of 60–70% Ig‐bearing cells together with a subpopulation of cells responding to soluble PHA. Separation of multiparous LNC on glass beads coated with rat Ig and then rabbit anti‐rat Ig (in excess) also demonstrated the retained cell population to be cytotoxic against tumour cells. Approximately 17–20% of the original cell population was recovered from cells retained on the column, and consisted of an enriched Ig‐bearing cell population (65–80% Ig‐bearing cells) and LNC responsive to PHA. Carbonyl iron treatment of multiparous rat LNC was found to remove detectable cytotoxicity from multiparous rat LNC preparations. The cytotoxicity of multiparous rat LNC retained on nylon wool was also abolished following incubation with carbonyl iron. Definite conclusions as to the nature of the effector cell cannot be drawn from this test, since carbonyl iron treatment was found to remove not only phagocytic cells from LNC preparations but also a proportion of other cell populations including Ig‐bearing lymphocytes. In addition to detecting a cytotoxic LNC population reactive towards tumour‐associated embryonic antigens (retained fraction from nylon‐wool column separation), a subpopulation of multiparous rat LNC was demonstrated in cell fractions eluted from the nylon wool which was shown to suppress the cytotoxicity of the retained multiparous LNC population. The exact nature of this subpopulation of LNC and the mechanism of action is at present not known.
📜 SIMILAR VOLUMES
## Abstract A variety of tumours injected into rats were found to rapidly stimulate cytotoxicity which was similar to naturally‐occurring cytotoxicity of normal rats. Cytotoxic cells from the spleen and peritoneal cavity closely resembled NK cells in their lytic specificity and cell‐surface charact
## Abstract Studies in mice and in humans have provided most of the available information concerning natural cell‐mediated cytotoxicity. Rats represent a second experimental species which is well suited for the study of natural cytotoxicity. Our studies indicate that the distribution of natural kil
## Abstract The use of germanium (Ge) and the possibility of exposure to trace and ultratrace amounts of this element is increasing. Germanium is widely used in the industrial field as a semiconductor and also as a dietary supplement, an elixir to ‘promote health and cure disease’ (e.g. cancer and
Kupffer cells play important roles in the development of liver injury by producing cytokines and free radicals. In consequence inhibition of these inflammatory mediators will be one of the targets for treating liver diseases. Retinoids modulate a wide variety of functions of monocytes/macrophages. C